Russell Investments Group
HBIO icon

Russell Investments Group’s Harvard Bioscience HBIO Stock Holding History

Russell Investments Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31
Closed -$173 – 3895
2025
Q1 		$173 Sell
31
-262
-89% -$3.35K ﹤0.01% 3736
2024
Q4 		$6.17K Sell
293
-29,830
-99% -$685K ﹤0.01% 3237
2024
Q3 		$810K Sell
30,123
-12,179
-29% -$359K ﹤0.01% 2110
2024
Q2 		$1.21M Buy
42,302
+42,297
+845,940% +$1.48M ﹤0.01% 1881
2024
Q1 		$229 Hold
5
– – ﹤0.01% 3268
2023
Q4 		$289 Sell
5
-9
-64% -$406 ﹤0.01% 3158
2023
Q3 		$615 Buy
+14
New +$646 ﹤0.01% 3383
2021
Q2 		– Sell
-940
Closed -$51K – 3250
2021
Q1 		$51K Sell
940
-1,169
-55% -$56.9K ﹤0.01% 3035
2020
Q4 		$90K Hold
2,109
– – ﹤0.01% 2873
2020
Q3 		$63K Sell
2,109
-167
-7% -$5.62K ﹤0.01% 3051
2020
Q2 		$70K Buy
2,276
+940
+70% +$25.3K ﹤0.01% 2944
2020
Q1 		$28K Hold
1,336
– – ﹤0.01% 2921
2019
Q4 		$39K Hold
1,336
– – ﹤0.01% 3008
2019
Q3 		$40K Sell
1,336
-35,851
-96% -$891K ﹤0.01% 2939
2019
Q2 		$745K Buy
37,187
+1,252
+3% +$36.7K ﹤0.01% 2108
2019
Q1 		$1.55M Buy
35,935
+33,711
+1,516% +$1.22M ﹤0.01% 1848
2018
Q4 		$68K Sell
2,224
-392
-15% -$15.5K ﹤0.01% 2766
2018
Q3 		$136K Hold
2,616
– – ﹤0.01% 2717
2018
Q2 		$137K Sell
2,616
-1,090
-29% -$55.8K ﹤0.01% 2706
2018
Q1 		$186K Buy
3,706
+1,090
+42% +$48.9K ﹤0.01% 2668
2017
Q4 		$85K Hold
2,616
– – ﹤0.01% 2805
2017
Q3 		$98K Hold
2,616
– – ﹤0.01% 2777
2017
Q2 		$67K Hold
2,616
– – ﹤0.01% 2852
2017
Q1 		$68K Hold
2,616
– – ﹤0.01% 2861
2016
Q4 		$76K Buy
+2,616
New +$66.5K ﹤0.01% 2930

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group's HBIO Position: Q2 2025 in Review

Russell Investments Group sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 31 shares — an estimated $173 sold.

Russell Investments Group first reported a position in HBIO in Q4 2016 and held it in 25 quarters. The position peaked at $1.55M in Q1 2019. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Russell Investments Group reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 31 Harvard Bioscience shares in Q2 2025, an estimated $173.
  • Russell Investments Group first reported a position in Harvard Bioscience in Q4 2016 and held it in 25 quarters.
  • Russell Investments Group's Harvard Bioscience position peaked at $1.55M in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.